CXCL12 and triple-negative breast carcinoma: In triple negative breast cancer patients, high cytoplasmic CXCR4 expression was related to lower distant recurrence and better recurrence-free survival, while high CXCL12 expression was associated with larger tumor size, positive lymph node metastasis, and higher pathologic stage [14].